Serum acute phase protein concentrations in dogs with hyperadrenocorticism with and without concurrent inflammatory conditions

Veterinary Clinical Pathology

Volumn 38, Issue 1, 2009, Pages 63-68

  Caldin, Marco ^a   Tasca, Silvia ^b   Carli, Erika ^b   Bianchini, Silvia ^a   Furlanello, Tommaso ^a   Martinez Subiela, Silvia ^c   Cerón, Jose J ^c  

^a San Marco Veterinary Hospital   (Italy)

^b San Marco Private Veterinary Laboratory   (Italy)

^c Veterinary School   (Spain)

Author keywords

Acute phase protein; Dog; Hyperadrenocorticism; Inflammation

Indexed keywords

CANIS FAMILIARIS;

ACUTE PHASE PROTEIN;

ADRENAL CORTEX HYPERFUNCTION; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; FEMALE; INFLAMMATION; MALE; METABOLISM;

ACUTE-PHASE PROTEINS; ADRENOCORTICAL HYPERFUNCTION; ANIMALS; DOG DISEASES; DOGS; FEMALE; INFLAMMATION; MALE;

EID: 67549090545     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2008.00087.x     Document Type: Article

References (25)

1. Murata H, Shimada N, Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J. 2004;168:28-40.
2. Ceron JJ, Eckersall PD, Martínez Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol. 2005;34:85-99.
3. Solter PF, Hoffmann WE, Hungerford LL, et al. Haptoglobin and ceruloplasmin as determinants of inflammation in dogs. Am J Vet Res. 1991;52: 1738-1742.
4. Matijatko V, Mrljak V, Kis I, et al. Evidence of an acute phase response in dogs naturally infected with Babesia canis. Vet Parasitol. 2007;144:242-250.
5. Mc Grotty YL, Knottenbelt CM, Ramsey IK, Reid SWJ, Eckersall PD. Haptoglobin concentrations in a canine hospital population. Vet Rec. 2003;152:562-564.
6. Mc Grotty YL, Arteaga A, Knottenbelt CM, Ramsey IK, Eckersall PD. Haptoglobin concentrations in dogs undergoing trilostane treatment for hyperadrenocorticism. Vet Clin Pathol. 2005;34:255-258.
7. Nichols R. Complications and concurrent disease associated with canine hyperadrenocorticism. Vet Clin North Am Small Anim Pract. 1997;27:309-320.
8. Forrester SD, Troy GC, Dalton MN, Huffman JV, Holtzman G. Retrospective evaluation of urinary tract infection in 42 dogs with hyperadrenocorticism or diabetes mellitus or both. J Vet Intern Med. 1999;13:557-560.
9. Bertolini G, Rossetti E, Caldin M. Pituitary apoplexylike disease in 4 dogs. J Vet Int Med. 2007;21:1251-1257.
10. Martinez-Subiela S, Ceron JJ. Validation of commercial assays for the determination of haptoglobin, C-reactive protein and serum amyloid A in dogs. Arch Med Vet. 2005;37:61-66.
11. Martinez Subiela S, Ceron JJ. Evaluation of acute phase protein indexes in dogs with leishmaniosis at diagnosis, during and after short-term treatment. Vet Med-Czech. 2005;50:39-46.
12. Yamamoto S, Shida T, Okimura T, et al. Determination of C-reactive protein in serum and plasma from healthy dogs and dogs with pneumonia by ELISA and slide reversed passive latex agglutination test. Vet Q. 1994;16:74-77.
13. Kuribayashi T, Shimada T, Matsumoto M, et al. Determination of serum C-reactive protein (CRP) in healthy beagle dogs of various ages and pregnant beagle dogs. Exp Anim. 2003;52:387-390.
14. Vannucchi CI, Mirnadola RM, Oliveira CM. Acute phase protein profile during gestation and diestrous: proposal for an early pregnancy test in bitches. Anim Reprod Sci. 2002;74:87-99.
15. Martinez Subiela S, Ginel PJ, Ceron JJ. Effects of different glucocorticoid treatments on serum acute phase proteins in dogs. Vet Rec. 2004;154:814-817.
16. Jacoby RC, Owings JT, Ortega T, Gosselin R, Feldman ED. Biochemical basis for the hypercoagulable state seen in Cushing syndrome. Arch Surg. 2001;136: 1003-1006.
17. Ramsey IK, Tebb A, Harris E, Evans H, Herrtage ME. Hyperparathyroidism in dogs with hyperadrenocorticism. J Small Anim Pract. 2005;46:531-536.
18. Yamaji T, Ishibashi M, Yamada A, et al. Plasma levels of atrial natriuretic hormone in Cushings syndrome. J Clin Endocrinol Metab. 1988;67:348-352.
19. Campbell J, Rastogi KS. Elevation in serum insulin, albumin, and FFA, with gains in liver lipids and protein, induced by glucocorticoid treatment in dogs. Can J Physiol Pharmacol. 1968;46:421-429.
20. Moore GE, Mahaffey EA, Hoenig M. Hematologic and serum biochemical effects of long-term administration of antinflammatory doses of prednisone in dogs. Am J Vet Res. 1992;53:1033-1037.
21. Langlais-Burgess L, Lumsden JH, Mackin A. Concurrent hypadrenocorticism and hypoalbuminemia in dogs: a retrospective study. J Am Anim. Hosp Assoc. 1995;31:307-311.
22. Grahan MF, Willey A, Zhu YN, et al. Corticosteroids repress the interleukin 1 beta-induced secretion of collagenase in human intestinal smooth muscle cells. Gastroenterology. 1997;113:1924-1929.
23. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids. Science. 1995;270:283-286.
24. Perry CG, Cleland SJ, Connell JM, Petrie JR, Sattar N. Low grade inflammation is notably suppressed by conventional anti-inflammatory treatment: a randomised crossover trial. Heart. 2004;90:804-805.
25. Goldstein RN, Ryu K, Khrestian C, van Wagoner DR, Waldo AL. Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model. J Cardiovasc Electrophysiol. 2008;19:74-81.